(Q34723802)

4 August 2017

1 reference

title

Pefloxacin clinical pharmacokinetics (English)

1 reference

4 August 2017

1 reference

Bressolle F

1

1 reference

4 August 2017

Gonçalves F

series ordinal

2

1 reference

4 August 2017

Gouby A

series ordinal

3

1 reference

4 August 2017

Galtier M

series ordinal

4

1 reference

4 August 2017

publication date

1 December 1994

1 reference

Clinical Pharmacokinetics

4 August 2017

published in

1 reference

4 August 2017

volume

27

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

418-446

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199427060-00003

4 August 2017

exact match

0 references

cites work

Interaction between the fluoroquinolones and the bronchodilator theophylline

1 reference

12 December 2020

Pharmacokinetics of pefloxacin in normal and impaired renal function

1 reference

12 December 2020

Pharmacokinetics of single-dose intravenous, oral, and intraperitoneal pefloxacin in patients on chronic ambulatory peritoneal dialysis

1 reference

12 December 2020

Concentration of pefloxacine in split ejaculates of patients with chronic male accessory gland infection

1 reference

12 December 2020

Intraperitoneal penetration of pefloxacin

1 reference

12 December 2020

Pharmacokinetics of three newer quinolones in pregnant and lactating women

1 reference

12 December 2020

The comparative pharmacokinetics of five quinolones

1 reference

12 December 2020

Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells

1 reference

12 December 2020

Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages

1 reference

12 December 2020

Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline

1 reference

12 December 2020

Inhibition of DNA replication in vitro by pefloxacin

1 reference

12 December 2020

Steady-state levels of pefloxacin and its metabolites in patients with severe renal impairment

1 reference

12 December 2020

Bactericidal activities of five quinolones for Escherichia coli strains with mutations in genes encoding the SOS response or cell division

1 reference

12 December 2020

Bacterial resistance to quinolones: mechanisms and clinical importance.

1 reference

12 December 2020

Structure-activity relationships of the fluoroquinolones

1 reference

12 December 2020

A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora

1 reference

12 December 2020

Treatment of bacterial meningitis

1 reference

12 December 2020

Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus

1 reference

12 December 2020

[Pharmacokinetic behavior of pefloxacin in man]

1 reference

12 December 2020

Penetration of pefloxacin into gynaecological tissues

1 reference

12 December 2020

Pefloxacin penetration of renal parenchyma

1 reference

12 December 2020

Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour

1 reference

12 December 2020

Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

1 reference

12 December 2020

[Pefloxacine: diffusion into bronchial mucus]

1 reference

12 December 2020

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

12 December 2020

Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers

1 reference

12 December 2020

Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage.

1 reference

12 December 2020

The pH of the Prostatic Fluid in Health and Disease:Implications of Treatment in Chronic Bacterial Prostatitis

1 reference

12 December 2020

Multiple-dose pharmacokinetics of pefloxacin in patients with hepatocellular deficiency

1 reference

12 December 2020

Comparative study of intramacrophagic penetration and action on phagocytosis of a macrolide (spiramycin) and a fluoroquinolone (pefloxacin)

1 reference

12 December 2020

Decreased erythrocyte penetration of pefloxacin in cirrhotic patients.

1 reference

12 December 2020

Pefloxacin kinetics in cirrhosis

1 reference

12 December 2020

Quinolone antibacterials. An update of their pharmacology and therapeutic use.

1 reference

12 December 2020

Penetration of pefloxacin into human allograft pancreatic juice

1 reference

12 December 2020

Pefloxacin in the antibacterial treatment of immunodepressed patients

1 reference

12 December 2020

[Intracameral penetration of pefloxacine in man]

1 reference

12 December 2020

[Use of an antibioprophylaxis with pefloxacin and fosfomycin in cardiac surgery in patients with beta-lactam hypersensitivity]

1 reference

12 December 2020

The influence of quinolone derivatives on theophylline clearance

1 reference

12 December 2020

Pharmacokinetic disposition of quinolones in human body fluids and tissues

1 reference

12 December 2020

[Treatment of peritonitis in kidney failure patients under continuous ambulatory peritoneal dialysis by pefloxacine. Results and pharmacokinetics]

1 reference

12 December 2020

Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1

1 reference

12 December 2020

Use of fluoroquinolones for intracellular pathogens

1 reference

12 December 2020

Chronic Bacterial Prostatitis and the Diffusion of Drugs into Prostatic Fluid

1 reference

12 December 2020

Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue

1 reference

12 December 2020

Antimicrobial penetration into polymorphonuclear leukocytes and alveolar macrophages

1 reference

12 December 2020

Intravitreal penetration of oral pefloxacin in humans

1 reference

12 December 2020

Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations

1 reference

12 December 2020

Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of fluoroquinolones in hepatic failure

1 reference

12 December 2020

Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD)

1 reference

12 December 2020

Effect of new quinolones on the human gastrointestinal microflora.

1 reference

12 December 2020

Peritonitis during continuous ambulatory peritoneal dialysis. Treatment with pefloxacin: first results and pharmacokinetics

1 reference

12 December 2020

Penetration of pefloxacin into maxillary sinus cavity and nasal secretions

1 reference

12 December 2020

Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis

1 reference

12 December 2020

Clinical pharmacokinetics of the newer antibacterial 4-quinolones

1 reference

12 December 2020

Decreased absorption of pefloxacin by gastric antacids. Preliminary study

1 reference

12 December 2020

Bactericidal mechanisms of ofloxacin.

1 reference

12 December 2020

Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers

1 reference

12 December 2020

Intracellular distribution and activity of antibiotics

1 reference

12 December 2020

[Kinetics of pefloxacin diffusion in human bone tissue following a single infusion of 800 mg. Evaluation of an extraction technic using chloroform]

1 reference

12 December 2020

Diffusion of pefloxacin in the aqueous humor and crystalline lens after repeated oral administration in man

1 reference

12 December 2020

Drug therapy in continuous ambulatory peritoneal dialysis patients

1 reference

12 December 2020

The quinolones in chronic bronchitis

1 reference

12 December 2020

Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis

1 reference

12 December 2020

Pefloxacin concentrations in human aqueous humour and lens

1 reference

12 December 2020

Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans

1 reference

12 December 2020

Pharmacokinetics of pefloxacin in renal insufficiency

1 reference

12 December 2020

Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man.

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of orally administered pefloxacin

1 reference

12 December 2020

Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans

1 reference

12 December 2020

[Clinical and pharmacokinetic study of pefloxacin in spontaneous ascitic fluid infections]

1 reference

12 December 2020

Pharmacokinetics and bactericidal activities of one 800-milligram dose versus two 400-milligram doses of intravenously administered pefloxacin in healthy volunteers

1 reference

12 December 2020

Penetration of pefloxacin in human heart valves.

1 reference

12 December 2020

Plasma and dialysate levels of pefloxacin and its metabolites in CAPD patients with peritonitis

1 reference

12 December 2020

The comparative in-vitro activity of pefloxacin.

1 reference

12 December 2020

The diffusion of pefloxacin into bone and the treatment of osteomyelitis

1 reference

12 December 2020

Relationship between chemical structure of antibiotics and pharmacokinetics.

1 reference

12 December 2020

Potential role of fluoroquinolones in the treatment of bacterial meningitis

1 reference

12 December 2020

Penetration of pefloxacin into bronchial secretions

1 reference

12 December 2020

10.2165/00003088-199427060-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1040630596

0 references

1 reference